Cellectis S.A. (EPA:ALCLS)
France · Delayed Price · Currency is EUR 4.435
-0.010 (-0.22%)
At close: Nov 28, 2025
Cellectis Market Cap
Cellectis has a market cap or net worth of €320.76 million as of November 28, 2025. Its market cap has increased by 156.78% in one year.
Market Cap
320.76M
Enterprise Value
351.96M
Revenue
70.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
€4.44
Market Cap Chart
Since February 7, 2007, Cellectis's market cap has increased from 100.59M to 320.76M, an increase of 218.87%. That is a compound annual growth rate of 6.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 320.76M | 173.48% |
| Dec 31, 2024 | 117.29M | -40.86% |
| Dec 29, 2023 | 198.32M | 118.98% |
| Dec 30, 2022 | 90.57M | -73.23% |
| Dec 31, 2021 | 338.35M | -67.37% |
| Dec 31, 2020 | 1.04B | 55.81% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 142.36B |
| Sanofi | 104.35B |
| Sartorius Stedim Biotech | 20.17B |
| bioMérieux | 12.74B |
| Eurofins Scientific SE | 10.39B |
| Ipsen | 10.21B |
| ABIVAX Société Anonyme | 8.16B |
| Virbac | 3.08B |